125 related articles for article (PubMed ID: 8683901)
1. CD7 positive acute lymphoblastic leukemia successfully treated with high dose cytosine arabinoside and mitoxantrone: a case report.
Nakajima H; Kizaki M; Kawai Y; Ishida A; Tokuhira M; Watanabe K; Ikeda Y
Keio J Med; 1996 Jun; 45(2):114-7. PubMed ID: 8683901
[TBL] [Abstract][Full Text] [Related]
2. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia.
Liso V; Specchia G; Capalbo S; Pavone V; Iacobazzi A; Iaculli ML; Dione R; Pansini N
Acta Haematol; 1992; 87(1-2):54-7. PubMed ID: 1585771
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.
Rosen PJ; Rankin C; Head DR; Boldt DH; Luthardt FW; Norwood T; Pugh RP; Karanes C; Appelbaum FR
Leuk Res; 2000 Mar; 24(3):183-7. PubMed ID: 10738999
[TBL] [Abstract][Full Text] [Related]
5. Mitoxantrone and standard dose cytosine arabinoside therapy in refractory or relapsed acute leukemia.
Keskin A; Tombuloğlu M; Atamer MA; Büyükkeçeci F
Acta Haematol; 1994; 92(1):14-7. PubMed ID: 7985476
[TBL] [Abstract][Full Text] [Related]
6. [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
Doi T; Sakamaki S; Koike K; Matsunaga T; Kobayashi D; Muramatsu H; Sato T; Watanabe N; Kougo Y; Niitsu Y
Rinsho Ketsueki; 1996 Aug; 37(8):676-81. PubMed ID: 8827877
[TBL] [Abstract][Full Text] [Related]
7. [Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].
Tsukaguchi M; Furukawa Y; Kitani T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1603-7. PubMed ID: 9725056
[TBL] [Abstract][Full Text] [Related]
8. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia.
Kantarjian HM; Walters RL; Keating MJ; Estey EH; O'Brien S; Schachner J; McCredie KB; Freireich EJ
Cancer; 1990 Jan; 65(1):5-8. PubMed ID: 2293869
[TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
11. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: response to treatment and factors influencing outcome.
Sierra J; Grañena A; Bosch F; Carreras E; Martí JM; Urbano-Ispizua A; Rovira M; Rozman C
Hematol Oncol; 1992; 10(6):301-9. PubMed ID: 1296931
[TBL] [Abstract][Full Text] [Related]
13. Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.
Arlin ZA; Feldman EJ; Finger LR; Ahmed T; Mittelman A; Cook P; Puccio C; Baskind P; Arnold P; Razis ED
Leukemia; 1991 Aug; 5(8):712-4. PubMed ID: 1886423
[TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
Hiddemann W; Büchner T; Heil G; Schumacher K; Diedrich H; Maschmeyer G; Ho AD; Planker M; Gerith-Stolzenburg S; Donhuijsen-Ant R
Leukemia; 1990 Sep; 4(9):637-40. PubMed ID: 2395383
[TBL] [Abstract][Full Text] [Related]
15. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone.
Weiss M; Maslak P; Feldman E; Berman E; Bertino J; Gee T; Megherian L; Seiter K; Scheinberg D; Golde D
J Clin Oncol; 1996 Sep; 14(9):2480-5. PubMed ID: 8823326
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
[TBL] [Abstract][Full Text] [Related]
17. Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine.
Raanani P; Shpilberg O; Gillis S; Avigdor A; Hardan I; Berkowicz M; Sofer O; Lossos I; Chetrit A; Ben-Yehuda D; Ben-Bassat I
Leuk Res; 1999 Aug; 23(8):695-700. PubMed ID: 10456666
[TBL] [Abstract][Full Text] [Related]
18. [Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy 7 successfully treated with intermediate- and high-dose ara-C].
Hatsuse M; Shimazaki C; Tsubakimoto Y; Ochiai N; Okano A; Ashihara E; Inaba T; Fujita N; Nakagawa M
Rinsho Ketsueki; 2001 Feb; 42(2):115-8. PubMed ID: 11280917
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens.
Lin MT; Chen YC; Liu TW; Tien HF; Liu MC; Wang CH; Shen MC; Liu CH
Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1116-22. PubMed ID: 2636248
[TBL] [Abstract][Full Text] [Related]
20. High-dose cytosine arabinoside and mitoxantrone in previously-treated acute leukemia patients.
Lejeune C; Tubiana N; Gastaut JA; Maraninchi D; Richard B; Launay MC; Sainty D; Sebahoun G; Carcassonne Y
Eur J Haematol; 1990 Apr; 44(4):240-3. PubMed ID: 2344886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]